AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / PHARMACEUTICAL PREPARATIONS
Phibro Animal Health Corporation Class A
XNAS · usd
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG0069NW5X3
38.80▼ 1.01 (-2.54%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close
39.81
Day's Range
38.62 – 39.51
52-Week Range
28.25 – 61.20
Volume
102.8K
Avg Volume
235.0K
Share Statistics
Shares Outstanding
Employees
2,475
Exchange
XNAS
Listed
2014-04-11
Share count as of August 21, 2026

Phibro Animal Health Corporation Class A (PAHC) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Phibro Animal Health Corporation Class A (PAHC)
What is Phibro Animal Health Corporation Class A's Market Cap?
Phibro Animal Health Corporation Class A's Market Cap is $1.6B, based on as-reported figures from SEC (XBRL) filings.
What is Phibro Animal Health Corporation Class A's Enterprise Value?
Phibro Animal Health Corporation Class A's Enterprise Value is $2.2B, based on as-reported figures from SEC (XBRL) filings.
What is Phibro Animal Health Corporation Class A's Trailing P/E?
Phibro Animal Health Corporation Class A's Trailing P/E is 15.8×, based on as-reported figures from SEC (XBRL) filings.
What is Phibro Animal Health Corporation Class A's Price / Sales?
Phibro Animal Health Corporation Class A's Price / Sales is 1.0×, based on as-reported figures from SEC (XBRL) filings.
What is Phibro Animal Health Corporation Class A's EV / Revenue?
Phibro Animal Health Corporation Class A's EV / Revenue is 1.5×, based on as-reported figures from SEC (XBRL) filings.
What is Phibro Animal Health Corporation Class A's EV / EBITDA?
Phibro Animal Health Corporation Class A's EV / EBITDA is 9.1×, based on as-reported figures from SEC (XBRL) filings.
What is Phibro Animal Health Corporation Class A's Revenue (TTM)?
Phibro Animal Health Corporation Class A's Revenue (TTM) is $1.5B, based on as-reported figures from SEC (XBRL) filings.
What is Phibro Animal Health Corporation Class A's Net Income (TTM)?
Phibro Animal Health Corporation Class A's Net Income (TTM) is $99.7M, based on as-reported figures from SEC (XBRL) filings.
What is Phibro Animal Health Corporation Class A's EBITDA?
Phibro Animal Health Corporation Class A's EBITDA is $245.9M, based on as-reported figures from SEC (XBRL) filings.
What is Phibro Animal Health Corporation Class A's Diluted EPS (TTM)?
Phibro Animal Health Corporation Class A's Diluted EPS (TTM) is 2.46, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · PAHCAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in millions of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
CONSOLIDATED STATEMENTS OF OPERATIONS
Net sales
YoY growth+4.8%+10.3%+20.9%+39.7%
Cost of goods sold
Gross profit
% of revenue33.9%32.8%35.5%32.9%
Selling, general and administrative expenses
Operating income
% of revenue12.1%11.6%13.5%14.1%
Interest expense, net
Foreign currency losses, net
Income before income taxes
Provision for income taxes
Net income
% of revenue5.5%6.3%7.3%7.3%
Basic (in dollars per share)
Diluted (in dollars per share)